Literature DB >> 10753864

SOX9 enhances aggrecan gene promoter/enhancer activity and is up-regulated by retinoic acid in a cartilage-derived cell line, TC6.

I Sekiya1, K Tsuji, P Koopman, H Watanabe, Y Yamada, K Shinomiya, A Nifuji, M Noda.   

Abstract

SOX9 is a transcription factor that plays a key role in chondrogenesis. Aggrecan is one of the major structural components in cartilage; however, the molecular mechanism of aggrecan gene regulation has not yet been fully elucidated. TC6 is a clonal chondrocytic cell line derived from articular cartilage. The purpose of this study was to examine whether SOX9 modulates aggrecan gene expression and to further identify molecules that regulate Sox9 expression in TC6 cells. SOX9 overexpression in TC6 cells enhanced by approximately 3-fold the transcriptional activity of the AgCAT-8 construct containing 8-kilobase (kb) promoter/first exon/first intron fragments of the aggrecan gene. SOX9 enhancement of aggrecan promoter activity was lost when we deleted a 4.5-kb fragment from the 3'-end of the 8-kb fragment corresponding to the region including the first intron. In TC6 cells, SOX9 enhanced the transcriptional activity of a reporter construct containing the Sry/Sox consensus sequence >10-fold. SOX9 enhancement of aggrecan gene promoter activity and SOX9 transactivation through the Sry/Sox consensus sequence were not observed in osteoblastic osteosarcoma cells (ROS17/2.8), indicating the dependence on the cellular background. Northern blot analysis indicated that TC6 cells constitutively express Sox9 mRNA at relatively low levels. To examine regulation of Sox9 gene expression, we investigated the effects of calciotropic hormones and cytokines. Among these, retinoic acid (RA) specifically enhanced Sox9 mRNA expression in TC6 cells. The basal levels of Sox9 expression and its enhancement by RA were observed similarly at both permissive (33 degrees C) and nonpermissive (39 degrees C) temperatures. Furthermore, RA treatment enhanced the transcriptional activity of a reporter construct containing the Sry/Sox consensus sequence in TC6 cells. Moreover, RA treatment also enhanced the transcriptional activity of another reporter construct containing the enhancer region of the type II procollagen gene in TC6 cells. These observations indicate that SOX9 enhances aggrecan promoter activity and that its expression is up-regulated by RA in TC6 cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10753864     DOI: 10.1074/jbc.275.15.10738

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  161 in total

1.  Idiopathic weight reduction in mice deficient in the high-mobility-group transcription factor Sox8.

Authors:  E Sock; K Schmidt; I Hermanns-Borgmeyer; M R Bösl; M Wegner
Journal:  Mol Cell Biol       Date:  2001-10       Impact factor: 4.272

2.  Constitutive E2F1 overexpression delays endochondral bone formation by inhibiting chondrocyte differentiation.

Authors:  Blanca Scheijen; Marieke Bronk; Tiffany van der Meer; René Bernards
Journal:  Mol Cell Biol       Date:  2003-05       Impact factor: 4.272

3.  Shh establishes an Nkx3.2/Sox9 autoregulatory loop that is maintained by BMP signals to induce somitic chondrogenesis.

Authors:  Li Zeng; Hervé Kempf; L Charles Murtaugh; Mie Elissa Sato; Andrew B Lassar
Journal:  Genes Dev       Date:  2002-08-01       Impact factor: 11.361

4.  Basic helix-loop-helix transcription factor Twist1 inhibits transactivator function of master chondrogenic regulator Sox9.

Authors:  Shoujun Gu; Thomas G Boyer; Michael C Naski
Journal:  J Biol Chem       Date:  2012-04-24       Impact factor: 5.157

5.  L-Sox5 and Sox6 proteins enhance chondrogenic miR-140 microRNA expression by strengthening dimeric Sox9 activity.

Authors:  Satoshi Yamashita; Shigeru Miyaki; Yoshio Kato; Shigetoshi Yokoyama; Tempei Sato; Francisco Barrionuevo; Haruhiko Akiyama; Gerd Scherer; Shuji Takada; Hiroshi Asahara
Journal:  J Biol Chem       Date:  2012-04-30       Impact factor: 5.157

Review 6.  Potential of human embryonic stem cells in cartilage tissue engineering and regenerative medicine.

Authors:  Wei Seong Toh; Eng Hin Lee; Tong Cao
Journal:  Stem Cell Rev Rep       Date:  2011-09       Impact factor: 5.739

7.  Smad4 deficiency impairs chondrocyte hypertrophy via the Runx2 transcription factor in mouse skeletal development.

Authors:  Jianyun Yan; Jun Li; Jun Hu; Lu Zhang; Chengguo Wei; Nishat Sultana; Xiaoqiang Cai; Weijia Zhang; Chen-Leng Cai
Journal:  J Biol Chem       Date:  2018-05-07       Impact factor: 5.157

8.  Highly conserved proximal promoter element harbouring paired Sox9-binding sites contributes to the tissue- and developmental stage-specific activity of the matrilin-1 gene.

Authors:  Otgonchimeg Rentsendorj; Andrea Nagy; Ildikó Sinkó; Andreea Daraba; Endre Barta; Ibolya Kiss
Journal:  Biochem J       Date:  2005-08-01       Impact factor: 3.857

9.  Cav3.2 T-type calcium channel is required for the NFAT-dependent Sox9 expression in tracheal cartilage.

Authors:  Shin-Shiou Lin; Bing-Hsiean Tzeng; Kuan-Rong Lee; Richard J H Smith; Kevin P Campbell; Chien-Chang Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-28       Impact factor: 11.205

10.  Poly(γ-Glutamic Acid) as an Exogenous Promoter of Chondrogenic Differentiation of Human Mesenchymal Stem/Stromal Cells.

Authors:  Joana C Antunes; Roman Tsaryk; Raquel M Gonçalves; Catarina Leite Pereira; Constantin Landes; Christoph Brochhausen; Shahram Ghanaati; Mário A Barbosa; C James Kirkpatrick
Journal:  Tissue Eng Part A       Date:  2015-04-30       Impact factor: 3.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.